Trump FDA overhauls COVID-19 vaccine approval to focus on older populations, high-risk individuals
The Food and Drug Administration is shifting its annual COVID-19 vaccine approval policies to focus on Americans older than age 65 and other “high-risk” individuals, while increasing the standard of…
Devamını Oku
